Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Authors
-
Nirmal JainChairman, IIFL -
R. VenkataramanManaging Director, IIFL -
Abhimanyu SofatHead of Research, IIFL Securities -
Amar AmbaniHead - Research, IIFL -
Amar ChoudharyCEO & Co Founder, FinAskus -
Anil PharandeChairman -
Ankur ChoudharyCIO and Co-Founder, Goalwise -
Ankur VishnoiDerivative Analyst, IIFL Derivative Desk -
Anuj PuriChairman, ANAROCK Property Consultants -
Anuraag SabooCo-Founder & CEO, FundExpert -
Aparna HariSenior Manager - Corporate Communications, FundsIndia -
Devansh MehtaSenior Investment Advisor, IIFL -
Dharmesh JainPresident, MCHI-CREDAI and CMD, Nirmal Lifestyle -
Dr. Sunil GuptaFormer Director of PNB and Dena Bank -
Gunjan GoelDirector, Goel Ganga Developments -
Hadrien MendoncaSenior Technical Analyst, IIFL -
Harjot Singh NarulaFounder & CEO, ComparePolicy -
Harsh Vardhan SinghCo-founder & CEO, Tauro Investment Advisors -
Hitesh JainHead of Alternate Research -
Jasjeet SinghPartner – Financial Services Analytics, Advisory – EY India -
Jayesh BhanushaliSenior Derivative Analyst, IIFL -
JC SharmaVC and MD, Sobha Limited -
Jenny DaleyPresident and CEO, Omega Performance -
Jitender SinghDeputy Manager-Research, IIFL -
Johann VaucansonManaging Director, Edenred India -
Kishor PateCMD, Amit Enterprises Housing Ltd. -
Krunali ShahContent Writer, IIFL Securities -
M. RavichandranPresident – Insurance, TATA AIG General Insurance Company Limited -
Mandeep LambaManaging Director - Hotels, JLL India -
Manish BatwaraDeputy Vice President E- Broking India Private Client, IIFL -
Manish HermajaniCOO & Co-Founder, FinAskus -
Marek MachalaHead of Online, Home Credit India -
Mark StorrieSenior Underwriter - M&A, AIG -
Mohit SinghCBO, Finaskus -
Murali IyerIIFL -
Murali MalayappanManaging Director, Shriram Properties -
NarayanFounder & President, Integron India -
Naseem JavedChairman, Mentorian Worldwide -
Neel VyasSenior Investment Advisor, IIFL -
Nitin MishraSenior Vice-President – Products and Services, Netmagic -
Prashant TripathySenior Director and CFO, Max Life Insurance -
Pratik SealGroup CMO, AGS Transact Technologies -
Pritesh MehtaHead of Technicals Research, IIFL -
Rajas PednekarBlogger, IIFL -
Rajesh SudExecutive Vice Chairman & Managing Director, Max Life Insurance -
Rajiv RajCo-Founder & Director -
Ramesh NairCEO & Country Head, JLL India -
Raushan KumarDerivative Analyst, IIFL Derivative Desk -
Riddhi VyasContent Manager, IIFL Securities -
Ritesh PatelCommodity Analyst, IIFL Research -
Sachin BhardwajDirector, Marketing & Business Development -
Sachin ChandavarkarVice-President, New Initiatives -
SarabdeepCo-founder, bodhik -
Sharda TickooTechnical Head, Trend Micro India -
Shikha VermaAuthor & Seasoned Insurance Professional, ComparePolicy -
Shubhranshu PaniManaging Director - Strategic Consulting -
Siddharth ZarabiExecutive Editor, BTVi -
Soumitro ChakrabortyCEO, Fiinovation -
Subhajit BhattacharyaNews Editor, Dalal Street Investment Journal -
Sudhir RaikarContent Architect -
Sunny ChhabriaSouth Asia Sales Manager, Bloomberg LP -
Sushant SarinExecutive Vice President Commercial Lines, Tata AIG General Insurance -
Swati AggarwalCo-founder, ORO Wealth -
Tanuj KhoslaExecutive Member, CAIA Singapore -
Tarun MathurDirector of Life Insurance at Policybazaar -
Tejasvi MohanramCEO, RupeePower -
V ViswanandSenior Director & COO, Max Life Insurance -
Vidya BalaHead of Mutual Research, Fundsindia -
Vipin KhandelwalFounder, Unovest -
Yasser ZeineldinCEO, eHosting DataFort -
Yogesh MehraCEO & Co-founder, YOLO Homes -
Zoya BrarFounder and MD, Core Diagnostics
Categories
-
Bytes from a migrant mosquito!
by R. Venkataraman August 11, 2010 10:42 IST
Dear Mumbaikars:
Main Mast Macchar bol raha hoon. Apologies to Big Bee, after all he is also a part of our biradari. Remember how the Sena took on him too. -
Imagining India - where radiation fails!
by R. Venkataraman March 21, 2011 08:38 IST
Enough of doomsday scenarios have been forecast but I thought I’d take a lighter vein and imagine that any damage in India may actually be less than one would anticipate.
- Page
- 1
-
Thyrocare’s high B2B exposure helps it procure reagent at ~70% discount, thereby protecting margins. The 24% revenue ...
Buy Reco. Price: 549.25
-
Syngene is moving up in the CRO value chain by expanding its research capabilities and foraying in API manufacturing in FY20E. ...
Accumulate Reco. Price: 566.65